Yaldigo

Yaldigo (mesalazine) is a rectal medication used to treat mild to moderate ulcerative colitis symptoms. It delivers anti-inflammatory action directly to the colon for localized relief. This EU-manufactured treatment supports gastrointestinal health with targeted delivery. Ideal for those seeking localized relief from inflammatory bowel conditions.

Mesalazine, the active ingredient in Yaldigo, is primarily used to manage symptoms of ulcerative colitis, including inflammation and discomfort in the colon and rectum. It is often prescribed for mild to moderate flare-ups or maintenance therapy. This medication helps reduce irritation and supports the healing of the intestinal lining. People may use it when oral mesalazine isn’t sufficient or for targeted symptom control.

Yaldigo works locally in the rectum and lower colon to reduce inflammation and irritation. Users may notice a gradual reduction in symptoms such as urgency, bleeding, or discomfort during bowel movements. Since it acts directly at the site of inflammation, systemic effects are typically minimal. Some individuals experience mild rectal discomfort or changes in bowel habits during the first few uses.

Store Yaldigo at room temperature, away from moisture and heat. Keep the container tightly closed when not in use to maintain product integrity. Avoid inserting the applicator if there is significant rectal pain or bleeding unless directed by a healthcare professional. Always follow the handling instructions provided with the product to ensure safe and effective use.

No major drug interactions are commonly reported with Yaldigo due to its localized action in the rectum. However, concurrent use of other rectal medications may affect absorption or efficacy. Always inform your healthcare provider about all medications you are using, including over-the-counter products and supplements. Avoid combining with alcohol or other substances that may irritate the rectum.